INTEGRA LIFESCIENCES HOLDINGS CORPIART決算レポート
Nasdaq · health technology
Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| BlackRock, Inc. | 14.30% | 11.3M | ▲ +5.80pp | 2024-07-08 |
| The Vanguard Group | 10.06% | 7.8M | ▲ +1.09pp | 2024-08-12 |
| Fuller & Thaler Asset Management, Inc. | 5.11% | 4.0M | — | 2024-11-12 |
| Wellington Management Group LLP | 4.28% | 3.3M | — | 2024-02-09 |
| Champlain Investment Partners, LLC | 3.12% | 2.4M | — | 2024-02-13 |
| OF ABOVE PERSONS | 1.70% | 1.3M | ▼ -3.80pp | 2024-11-12 |
インサイダー取引
Net 90d: +$0 · buys $0 / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-03-11 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 18.9K | $0.00 | $0 |
| 2026-03-10 | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Option exercise | 1.2K | $0.00 | $0 |
1–2 of 2